Pd-Rx Pharmaceutical Correlations
| PDRX Stock | USD 3.33 0.00 0.00% |
The correlation of Pd-Rx Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Pd-Rx Pharmaceutical Correlation With Market
Poor diversification
The correlation between Pd Rx Pharmaceutical and DJI is 0.77 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pd Rx Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.
Pd-Rx |
The ability to find closely correlated positions to Pd-Rx Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pd-Rx Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pd-Rx Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pd Rx Pharmaceutical to buy it.
Moving together with Pd-Rx Pink Sheet
| 0.74 | GS | Goldman Sachs Group | PairCorr |
| 0.72 | BBDO | Banco Bradesco SA | PairCorr |
| 0.67 | AES | AES Aggressive Push | PairCorr |
| 0.82 | NTZ | Natuzzi SpA | PairCorr |
| 0.77 | LAND | Gladstone Land Earnings Call This Week | PairCorr |
| 0.87 | SLSR | Solaris Resources | PairCorr |
| 0.87 | TOGOF | TomaGold | PairCorr |
| 0.91 | CYD | China Yuchai Interna | PairCorr |
| 0.62 | MEGI | MainStay CBRE Global Normal Trading | PairCorr |
| 0.84 | GRBK | Green Brick Partners | PairCorr |
| 0.73 | DUK-PA | Duke Energy | PairCorr |
| 0.84 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.88 | CGECF | Cogeco Inc | PairCorr |
| 0.83 | USPH | US Physicalrapy | PairCorr |
| 0.61 | TORO | Toro | PairCorr |
| 0.87 | TATT | Tat Techno | PairCorr |
| 0.87 | INTC | Intel | PairCorr |
| 0.62 | FRFFF | Fairfax Financial | PairCorr |
| 0.86 | YLLXF | Yellow Cake plc Downward Rally | PairCorr |
| 0.91 | CAMZF | Camino Minerals | PairCorr |
| 0.86 | FRSB | First Resource Bank | PairCorr |
Moving against Pd-Rx Pink Sheet
| 0.86 | TRNR | Interactive Strength | PairCorr |
| 0.83 | APVO | Aptevo Therapeutics | PairCorr |
| 0.81 | NIVF | NewGenIvf Group | PairCorr |
| 0.59 | AFIIQ | Armstrong Flooring | PairCorr |
| 0.58 | BRK-A | Berkshire Hathaway Earnings Call This Week | PairCorr |
| 0.47 | VLCN | Volcon Inc Symbol Change | PairCorr |
| 0.32 | BAM | Brookfield Asset Man Normal Trading | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pd-Rx Pink Sheet performing well and Pd-Rx Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pd-Rx Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SPLTF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| OXBOF | 4.53 | 0.41 | 0.00 | 0.19 | 0.00 | 0.00 | 192.86 | |||
| MDBIF | 2.51 | (1.17) | 0.00 | 0.70 | 0.00 | 0.00 | 84.08 | |||
| MMJJF | 0.51 | 0.26 | 0.00 | (0.63) | 0.00 | 0.00 | 11.58 | |||
| NYMXF | 10.17 | 0.08 | 0.00 | 0.02 | 0.00 | 36.54 | 82.03 | |||
| UDOCF | 7.47 | 0.05 | 0.00 | 0.15 | 8.62 | 20.00 | 48.08 | |||
| TRUFF | 6.10 | (0.59) | 0.00 | (0.34) | 0.00 | 16.67 | 38.00 | |||
| ECGS | 12.86 | 0.53 | 0.00 | (0.02) | 17.70 | 35.71 | 153.46 | |||
| DVHGF | 347.25 | 186.89 | 0.00 | (0.97) | 0.00 | 0.00 | 6,004 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pd-Rx Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Pd-Rx Pharmaceutical Corporate Management
| RPh DO | CEO Chairman | Profile | |
| Jack II | Exec COO | Profile | |
| Robert Baker | Treasurer CFO | Profile | |
| Robert Surovec | Regulatory Officer | Profile |